Par Equity

Par Equity is a venture capital firm established in 2008 and headquartered in Edinburgh, United Kingdom. The firm focuses on investing in early-stage technology companies that demonstrate high growth potential, primarily within the regions of Northern England, Northern Ireland, and Scotland. Par Equity aims to support innovative businesses that contribute to the advancement of the technology sector in the North of the UK.

Andrew Castell

Partner

Claire Cramm

Investment Manager

Tom Croy

Investment Director

Robert Higginson

Partner

Oliver Johnston-Watt

Investment Analyst

Aidan MacMillan

Investment Director

Alastair Moore

Senior Investment Manager

Paul Munn

Partner

Andrew Noble

Partner

Elizabeth Young Ph.D

Investment Manager

Past deals in Augmented Reality

Neuranics

Seed Round in 2025
Neuranics is a company focused on developing advanced magnetic sensors integrated with semiconductor technology for applications in health, fitness, and the metaverse. Their proprietary technology is designed to detect minute magnetic impulses produced by the body's organs, utilizing scalable spintronics sensors. This innovative approach aims to address the limitations of current health monitoring devices and enhance human-machine interfaces. By leveraging magnetic sensing, Neuranics seeks to improve the interaction with the central, peripheral, and autonomic nervous systems, as well as muscles, thereby offering significant advancements for healthcare companies in creating next-generation wearable and implantable devices.

Neuranics

Pre Seed Round in 2023
Neuranics is a company focused on developing advanced magnetic sensors integrated with semiconductor technology for applications in health, fitness, and the metaverse. Their proprietary technology is designed to detect minute magnetic impulses produced by the body's organs, utilizing scalable spintronics sensors. This innovative approach aims to address the limitations of current health monitoring devices and enhance human-machine interfaces. By leveraging magnetic sensing, Neuranics seeks to improve the interaction with the central, peripheral, and autonomic nervous systems, as well as muscles, thereby offering significant advancements for healthcare companies in creating next-generation wearable and implantable devices.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.